CompletedNCT05417815
Interest of Nitazoxanide Treatment of Enterocytozoon Bieneusi Intestinal Microsporidiosis
Studying Microsporidiosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Clermont-Ferrand
- Principal Investigator
- Philippe Poirier, M.DUniversity Hospital, Clermont-Ferrand
- Enrollment
- 80 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2022
Study locations (24)
- CHU Amiens, Amiens, France
- CHU Besançon, Besançon, France
- CHU Bordeaux, Bordeaux, France
- CHU Brest, Brest, France
- CHU Caen, Caen, France
- CHU clermont-ferrand, Clermont-Ferrand, France
- CHU Dijon, Dijon, France
- CHU Grenoble, Grenoble, France
- CHU Lille, Lille, France
- CHU Limoges, Limoges, France
- Hospices Civils de Lyon, Lyon, France
- AP-HM, Marseille, France
- CHU Nancy, Nancy, France
- AP-HP Hopital Bichat Claude-Bernard, Paris, France
- AP-HP Hopital Necker-Enfants Malades, Paris, France
- +9 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05417815 on ClinicalTrials.govOther trials for Microsporidiosis
Additional recruiting or active studies for the same condition.